The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers
Open accessAbstract
Despite nearly two decades passing since the discovery of gene fusions involving TFE3 or TFEB in sporadic renal cell carcinoma (RCC), the molecular mechanisms underlying the renal-specific tumorigenesis of these genes remain largely unclear. The recently published findings of The Cancer Genome Atlas Network reported that five of the 416 surveyed clear cell RCC tumours (1.2%) harboured SFPQ–TFE3 fusions, providing further evidence for the importance of gene fusions. A total of five TFE3 gene fusions (PRCC–TFE3, ASPSCR1–TFE3, SFPQ–TFE3, NONO–TFE3, and CLTC–TFE3) and one TFEB gene fusion (MALAT1–TFEB) have been identified in RCC tumours and characterized at the mRNA transcript level. A multitude of molecular pathways well-described in carcinogenesis are regulated in part by TFE3 or TFEB proteins, including activation of TGFβ and ETS transcription factors, E-cadherin expression, CD40L-dependent lymphocyte activation, mTORC1 signalling, insulin-dependent metabolism regulation, folliculin signalling, and retinoblastoma-dependent cell cycle arrest. Determining which pathways are most important to RCC oncogenesis will be critical in discovering the most promising therapeutic targets for this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
TFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Motzer, R. J., Escudier, B., Oudard, S., Hutson, T. E., Porta, C., Bracarda, S., Grünwald, V., Thompson, J. A., Figlin, R. A., Hollaender, N., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61039-9 · Cited by 3,019
A Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Self-citationThe genomic complexity of primary human prostate cancer
Berger, M. F., Lawrence, M. S., Demichelis, F., Drier, Y., Cibulskis, K., Sivachenko, A. Y., Sboner, A., Esgueva, R., Pflueger, D., Sougnez, C., et al. (2011) · Nature · doi:10.1038/nature09744 · Cited by 1,234
Integrated molecular analysis of clear-cell renal cell carcinoma
Sato, Y., Yoshizato, T., Shiraishi, Y., Maekawa, S., Okuno, Y., Kamura, T., Shimamura, T., Sato-Otsubo, A., Nagae, G., Suzuki, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2699 · Cited by 1,221
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Varela, I., Tarpey, P., Raine, K., Huang, D., Ong, C. K., Stephens, P., Davies, H., Jones, D., Lin, M.-L., Teague, J., et al. (2011) · Nature · doi:10.1038/nature09639 · Cited by 1,123
BAP1 loss defines a new class of renal cell carcinoma
Peña-Llopis, S., Vega-Rubín-de-Celis, S., Liao, A., Leng, N., Pavía-Jiménez, A., Wang, S., Yamasaki, T., Zhrebker, L., Sivanand, S., Spence, P., et al. (2012) · Nature Genetics · doi:10.1038/ng.2323 · Cited by 959
Complex landscapes of somatic rearrangement in human breast cancer genomes
Stephens, P. J., McBride, D. J., Lin, M.-L., Varela, I., Pleasance, E. D., Simpson, J. T., Stebbings, L. A., Leroy, C., Edkins, S., Mudie, L. J., et al. (2009) · Nature · doi:10.1038/nature08645 · Cited by 845
McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y.-L., Ramaswamy, S., Avery, W., Ding, H.-F., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00762-6 · Cited by 760
The genetic basis of kidney cancer: a metabolic disease
Linehan, W. M., Srinivasan, R., & Schmidt, L. S. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.47 · Cited by 744
Self-citationRecognition by Max of its cognate DNA through a dimeric b/HLH/Z domain
Ferré-D'Amaré, A. R., Prendergast, G. C., Ziff, E. B., & Burley, S. K. (1993) · Nature · doi:10.1038/363038a0 · Cited by 724
Hemesath, T. J., Steingrímsson, E., McGill, G., Hansen, M. J., Vaught, J., Hodgkinson, C. A., Arnheiter, H., Copeland, N. G., Jenkins, N. A., & Fisher, D. E. (1994) · Genes & Development · doi:10.1101/gad.8.22.2770 · Cited by 673
Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene
Tassabehji, M., Newton, V. E., & Read, A. P. (1994) · Nature Genetics · doi:10.1038/ng1194-251 · Cited by 666
Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma
Argani, P., Antonescu, C. R., Illei, P. B., Lui, M. Y., Timmons, C. F., Newbury, R., Reuter, V. E., Garvin, A. J., Perez-Atayde, A. R., Fletcher, J. A., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61684-7 · Cited by 643
Ladanyi, M., Lui, M. Y., Antonescu, C. R., Krause-Boehm, A., Meindl, A., Argani, P., Healey, J. H., Ueda, T., Yoshikawa, H., Meloni-Ehrig, A., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204074 · Cited by 625
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
Bertolotto, C., Lesueur, F., Giuliano, S., Strub, T., de Lichy, M., Bille, K., Dessen, P., d’Hayer, B., Mohamdi, H., Remenieras, A., et al. (2011) · Nature · doi:10.1038/nature10539 · Cited by 526
Steingrímsson, E., Moore, K. J., Lamoreux, M. L., Ferré-D'Amaré, A. R., Burley, S. K., Sanders Zimring, D. C., Skow, L. C., Hodgkinson, C. A., Arnheiter, H., Copeland, N. G., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-256 · Cited by 493
Regulation of TFEB and V-ATPases by mTORC1
Peña-Llopis, S., Vega-Rubin-de-Celis, S., Schwartz, J. C., Wolff, N. C., Tran, T. A. T., Zou, L., Xie, X.-J., Corey, D. R., & Brugarolas, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.257 · Cited by 462
Beckmann, H., Su, L. K., & Kadesch, T. (1990) · Genes & Development · doi:10.1101/gad.4.2.167 · Cited by 457
Widlund, H. R., & Fisher, D. E. (2003) · Oncogene · doi:10.1038/sj.onc.1206443 · Cited by 371
Clark, J., Lu, Y.-J., Sidhar, S. K., Parker, C., Gill, S., Smedley, D., Hamoudi, R., Linehan, W. M., Shipley, J., & Cooper, C. S. (1997) · Oncogene · doi:10.1038/sj.onc.1201394 · Cited by 344
Self-citationTsuda, M., Davis, I. J., Argani, P., Shukla, N., McGill, G. G., Nagai, M., Saito, T., Laé, M., Fisher, D. E., & Ladanyi, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2855 · Cited by 306
Argani, P., Laé, M., Hutchinson, B., Reuter, V. E., Collins, M. H., Perentesis, J., Tomaszewski, J. E., Brooks, J. S. J., Acs, G., Bridge, J. A., et al. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146007.54092.37 · Cited by 289
Hua, X., Liu, X., Ansari, D. O., & Lodish, H. F. (1998) · Genes & Development · doi:10.1101/gad.12.19.3084 · Cited by 283
Morphologic and Molecular Characterization of Renal Cell Carcinoma in Children and Young Adults
Bruder, E., Passera, O., Harms, D., Leuschner, I., Ladanyi, M., Argani, P., Eble, J. N., Struckmann, K., Schraml, P., & Moch, H. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000131558.32412.40 · Cited by 280
Sidhar, S. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.9.1333 · Cited by 272
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23)
Argani, P., Lui, M. Y., Couturier, J., Bouvier, R., Fournet, J.-C., & Ladanyi, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206686 · Cited by 259
Davis, I. J., Hsi, B.-L., Arroyo, J. D., Vargas, S. O., Yeh, Y. A., Motyckova, G., Valencia, P., Perez-Atayde, A. R., Argani, P., Ladanyi, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931430100 · Cited by 247
Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling
Yasumoto, K.-I. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2703 · Cited by 228
Steingrímsson, E., Tessarollo, L., Pathak, B., Hou, L., Arnheiter, H., Copeland, N. G., & Jenkins, N. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072071099 · Cited by 227
Motyckova, G., Weilbaecher, K. N., Horstmann, M., Rieman, D. J., Fisher, D. Z., & Fisher, D. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091479298 · Cited by 219
Insight into the microphthalmia gene
Moore, K. J. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89143-x · Cited by 213
Nakagawa, Y., Shimano, H., Yoshikawa, T., Ide, T., Tamura, M., Furusawa, M., Yamamoto, T., Inoue, N., Matsuzaka, T., Takahashi, A., et al. (2006) · Nature Medicine · doi:10.1038/nm1334 · Cited by 209
Kuiper, R. P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg178 · Cited by 208
Weterman, M. A. J., Wilbrink, M., & van Kessel, A. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15294 · Cited by 206
Oncogenic MITF dysregulation in clear cell sarcoma: Defining the MiT family of human cancers
Davis, I. J., Kim, J. J., Ozsolak, F., Widlund, H. R., Rozenblatt-Rosen, O., Granter, S. R., Du, J., Fletcher, J. A., Denny, C. T., Lessnick, S. L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.021 · Cited by 202
Self-citationShibahara, S., Takeda, K., Yasumoto, K.-I., Udono, T., Watanabe, K.-I., Saito, H., & Takahashi, K. (2001) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.0022-202x.2001.00010.x · Cited by 184
Hong, S.-B., Oh, H., Valera, V. A., Baba, M., Schmidt, L. S., & Linehan, W. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015793 · Cited by 183
Self-citationThe metabolic basis of kidney cancer
Linehan, W. M., & Ricketts, C. J. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.06.002 · Cited by 181
Self-citationHughes, A. E., Newton, V. E., Liu, X. Z., & Read, A. P. (1994) · Nature Genetics · doi:10.1038/ng0894-509 · Cited by 171
Molecular Diagnosis and Therapy of Kidney Cancer
Linehan, W. M., Bratslavsky, G., Pinto, P. A., Schmidt, L. S., Neckers, L., Bottaro, D. P., & Srinivasan, R. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.042808.171650 · Cited by 167
Self-citationChoueiri, T. K., Lim, Z. D., Hirsch, M. S., Tamboli, P., Jonasch, E., McDermott, D. F., Cin, P. D., Corn, P., Vaishampayan, U., Heng, D. Y. C., et al. (2010) · Cancer · doi:10.1002/cncr.25512 · Cited by 162
Wagner, A. J., Goldberg, J. M., DuBois, S. G., Choy, E., Rosen, L. S., Pappo, A. S., Geller, J. I., Judson, I. R., Hogg, D., Senzer, N. N., et al. (2012) · Cancer · doi:10.1002/cncr.27582 · Cited by 159
Frequent mutations in the MITF pathway in melanoma
Cronin, J. C., Wunderlich, J., Loftus, S. K., Prickett, T. D., Wei, X., Ridd, K., Vemula, S., Burrell, A. S., Agrawal, N. S., Lin, J. C., et al. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00578.x · Cited by 158
Linkage of M-CSF Signaling to Mitf, TFE3, and the Osteoclast Defect in Mitfmi/mi Mice
Weilbaecher, K. N., Motyckova, G., Huber, W. E., Takemoto, C. M., Hemesath, T. J., Xu, Y., Hershey, C. L., Dowland, N. R., Wells, A. G., & Fisher, D. E. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00360-4 · Cited by 158
A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma
Farley, M. N., Schmidt, L. S., Mester, J. L., Peña‐Llopis, S., Pavía-Jiménez, A., Christie, A. L., Vocke, C. D., Ricketts, C. J., Peterson, J. C., Middelton, L. A., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0111 · Cited by 151
Self-citationHua, X., Miller, Z., Wu, G., Shi, Y., & Lodish, H. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13130 · Cited by 150
Luchin, A., Purdom, G., Murphy, K. M., Clark, M., Angel, N. Z., Cassady, A. I., Hume, D. A., & Ostrowski, M. C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.3.451 · Cited by 131
Zhao, G.-Q., Zhao, Q., Zhou, X., Mattéi, M., & Crombrugghe, B. D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4505 · Cited by 130
Fusion genes and chromosome translocations in the common epithelial cancers
Edwards, P. A. (2010) · The Journal of Pathology · doi:10.1002/path.2632 · Cited by 126
Molecular heterogeneity of TFE3 activation in renal cell carcinomas
Macher‐Goeppinger, S., Roth, W., Wagener, N., Hohenfellner, M., Penzel, R., Haferkamp, A., Schirmacher, P., & Aulmann, S. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.169 · Cited by 123
A Dominant Negative form of Transcription Activator mTFE3 Created by Differential Splicing
Roman, C. A. J., Cohn, L. E., & Calame, K. L. (1991) · Science · doi:10.1126/science.1840705 · Cited by 120
Takebayashi, K., Chida, K., Tsukamoto, I., Morii, E., Munakata, H., Arnheiter, H., Kuroki, T., Kitamura, Y., & Nomura, S. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1203 · Cited by 118
Identification of E-Box Factor TFE3 as a Functional Partner for the E2F3 Transcription Factor
Giangrande, P. H., Hallstrom, T. C., Tunyaplin, C., Calame, K. L., & Nevins, J. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.11.3707-3720.2003 · Cited by 114
Translocation Renal Cell Carcinomas in Adults
Zhong, M., Angelo, P. D., Osborne, L., Paniz‐Mondolfi, A., Geller, M. D., Yang, Y., Linehan, W. M., Merino, M. J., Cordon‐Cardo, C., & Cai, D. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31824f24a6 · Cited by 110
Self-citationSo, H., Rho, J., Jeong, D., Park, R., Fisher, D. E., Ostrowski, M. C., Choi, Y., & Kim, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302940200 · Cited by 110
Sensorineural Deafness and Pigmentation Genes
Price, E. R., & Fisher, D. E. (2001) · Neuron · doi:10.1016/s0896-6273(01)00259-8 · Cited by 102
Huan, C., Kelly, M. L., Steele, R., Shapira, I., Gottesman, S. R. S., & Roman, C. A. J. (2006) · Nature Immunology · doi:10.1038/ni1378 · Cited by 94
Meadows, N. A., Sharma, S. M., Faulkner, G. J., Ostrowski, M. C., Hume, D. A., & Cassady, A. I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608572200 · Cited by 91
Takemoto, C. M., Yoon, Y.-J., & Fisher, D. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201441200 · Cited by 86
Ugurel, S., Houben, R., Schrama, D., Voigt, H., Zapatka, M., Schadendorf, D., Bröcker, E., & Becker, J. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2682 · Cited by 83
A Big Gene Linked to Small Eyes Encodes Multiple Mitf Isoforms: Many Promoters Make Light Work
Yasumoto, K., Amae, S., Udono, T., Fuse, N., Takeda, K., & Shibahara, S. (1998) · Pigment Cell Research · doi:10.1111/j.1600-0749.1998.tb00491.x · Cited by 81
Weterman, M. A. J., van Groningen, J. J. M., Jansen, A., & van Kessel, A. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203255 · Cited by 79
Mitf Induction by RANKL Is Critical for Osteoclastogenesis
Lu, S.-Y., Li, M., & Lin, Y. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-07-0584 · Cited by 77
Weterman, M. A. J., van Groningen, J. J. M., Tertoolen, L. G. J., & van Kessel, A. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241304198 · Cited by 76
Verastegui, C., Bertolotto, C., Bille, K., Abbe, P., Ortonne, J. P., & Ballotti, R. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.3.0428 · Cited by 72
Skalsky, Y., Ajuh, P., Parker, C., Lamond, A. I., Goodwin, G. H., & Cooper, C. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204056 · Cited by 69
Transcriptional Activation by ETS and Leucine Zipper-Containing Basic Helix-Loop-Helix Proteins
Tian, G., Erman, B., Ishii, H., Gangopadhyay, S. S., & Sen, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2946 · Cited by 63
Inamura, K., Fujiwara, M., Togashi, Y., Nomura, K., Mukai, H., Fujii, Y., Yamamoto, S., Yonese, J., Fukui, I., & Ishikawa, Y. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182293ec3 · Cited by 58
Tachibana, M. (1997) · Pigment Cell Research · doi:10.1111/j.1600-0749.1997.tb00462.x · Cited by 56
Mathur, M., Das, S., & Samuels, H. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206643 · Cited by 41
Grinberg, A. V., & Kerppola, T. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211734200 · Cited by 41
The Absence of the Transcription Activator TFE3 Impairs Activation of B Cells In Vivo
Merrell, K. T., Wells, S. K., Henderson, A. J., Gorman, J. R., Alt, F. W., Stall, A. M., & Calame, K. L. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3335 · Cited by 41
Huan, C., Sashital, D., Hailemariam, T. K., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502380200 · Cited by 39
Weterman, M. A. J., Wilbrink, M., Dijkhuizen, T., van den Berg, E., & van Kessel, A. G. (1996) · Human Genetics · doi:10.1007/s004390050153 · Cited by 37
Transcription factor E3, a major regulator of mast cell–mediated allergic response
Yagil, Z., Erlich, T. H., Ofir‐Birin, Y., Tshori, S., Kay, G., Yekhtin, Z., Fisher, D. E., Chang, C. K., Wong, W. S. F., Hartmann, K., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.11.051 · Cited by 35
Mansky, K. C., Marfatia, K. A., Purdom, G., Luchin, A., Hume, D. A., & Ostrowski, M. C. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.2.295 · Cited by 35
IWASAKI, H. O., Naka, A., Iida, K., Nakagawa, Y., Matsuzaka, T., Ishii, K., Kobayashi, K., Takahashi, A., Yatoh, S., Yahagi, N., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00204.2011 · Cited by 34
The Mitotic Arrest Deficient Protein MAD2B Interacts with the Clathrin Light Chain A during Mitosis
Medendorp, K., Vreede, L., van Groningen, J. V., Hetterschijt, L., Brugmans, L., Jansen, P., van den Hurk, W. H., de Bruijn, D. D., & van Kessel, A. V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015128 · Cited by 32
Guo, T., Zhu, Y., Gan, C. S., Lee, S. S., Zhu, J., Wang, H., Li, X., Christensen, J. G., Huang, S., Kon, O. L., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.001776 · Cited by 30
TFE3 transcription factor regulates the expression of MAFB during macrophage differentiation
Zanocco‐Marani, T., Vignudelli, T., Parenti, S., Gemelli, C., Condorelli, F., Martello, A., Selmi, T., Grande, A., & Ferrari, S. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.03.018 · Cited by 29
Nijman, S. M. B., Hijmans, E. M., Messaoudi, S. E., van Dongen, M. M. W., Sardet, C., & Bernards, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602312200 · Cited by 25
Cited by
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
The Cancer Genome Atlas Research Network (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505917 · Cited by 1,336
Napolitano, G., & Ballabio, A. (2016) · Journal of Cell Science · doi:10.1242/jcs.146365 · Cited by 845
Epidemiology of Renal Cell Carcinoma: 2022 Update
Bukavina, L., Bensalah, K., Bray, F., Carlo, M., Challacombe, B., Karam, J. A., Kassouf, W., Mitchell, T., Montironi, R., O'Brien, T., et al. (2022) · European Urology · doi:10.1016/j.eururo.2022.08.019 · Cited by 775
The Lysosome as a Regulatory Hub
Perera, R. M., & Zoncu, R. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125125 · Cited by 660
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications
Linehan, W. M., & Ricketts, C. J. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0211-5 · Cited by 621
Self-citation
Metadata
- Authors
- Kauffman, E. C., Ricketts, C. J., Rais-Bahrami, S., Yang, Y., Merino, M. J., Bottaro, D. P., Srinivasan, R., & Linehan, W. M.
- Venue
- Nature Reviews Urology
- Published
- 2014-08
- Volume
- 11
- Issue
- 8
- Pages
- 465-475
- ISSN
- 1759-4812 (ISSN-L)
- 1759-4820
- OpenAlex
- W2002583936
- Cited by
- 313
- References
- 85
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.